60 Degrees Pharmaceuticals, Inc.
SXTP
$0.95
-$0.02-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -32.48% | -36.75% | 16.24% | 256.92% | 144.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.48% | -36.75% | 16.24% | 256.92% | 144.95% |
| Cost of Revenue | 165.89% | -17.32% | 3.77% | 28.11% | -91.15% |
| Gross Profit | -2,192.28% | -9.21% | 3.61% | 9.37% | 100.85% |
| SG&A Expenses | 5.94% | 9.68% | -8.18% | 23.99% | 44.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.51% | 4.15% | -4.44% | 25.91% | -55.63% |
| Operating Income | -41.39% | -9.63% | 7.16% | -9.76% | 61.65% |
| Income Before Tax | -30.59% | -11.34% | 29.70% | -7.25% | 58.43% |
| Income Tax Expenses | -- | -- | -125.00% | 0.00% | -- |
| Earnings from Continuing Operations | -30.59% | -11.34% | 29.76% | -7.24% | 58.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.33% | 12.50% | -87.18% | 0.00% | -20.00% |
| Net Income | -30.62% | -11.33% | 29.65% | -7.25% | 58.45% |
| EBIT | -41.39% | -9.63% | 7.16% | -9.76% | 61.65% |
| EBITDA | -41.19% | -9.24% | 7.59% | -9.44% | 62.02% |
| EPS Basic | 82.11% | 79.36% | 83.86% | 85.72% | 94.03% |
| Normalized Basic EPS | 81.87% | 79.30% | 84.20% | 85.74% | 94.28% |
| EPS Diluted | 82.11% | 79.36% | 83.86% | 85.72% | 94.03% |
| Normalized Diluted EPS | 81.87% | 79.30% | 84.20% | 85.74% | 94.28% |
| Average Basic Shares Outstanding | 620.55% | 437.80% | 346.15% | 651.96% | 626.43% |
| Average Diluted Shares Outstanding | 620.55% | 437.80% | 346.15% | 651.96% | 626.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |